Back to Top Skip to main content Skip to sub-navigation

COVID-19 Convalescent plasma collection continues

Three units of CCP laying on a table The COVID-19 Convalescent Plasma, or CCP, collection campaign was a significant success in 2020. The DOD surpassed its goal by collecting more than 10,000 CCP units. The collection of CCP will to continue next year as well. (Photo by Jaciyn Matanane, Naval Hospital Guam.)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Defense Health Agency’s COVID-19 Convalescent Plasma, or CCP, collection was a significant success in 2020, exceeding its goal and helping more than 200 Department of Defense beneficiaries who had been hospitalized with the deadly disease.

The DOD campaign resulted in the acquisition of 10,745 units of the plasma donated by active-duty personnel, military retirees, their families, and non-DOD civilians who were designated as fully recovered from COVID-19. The goal of the secretary’s campaign, which ended Sept. 30, had been to collect 10,000 CCP units.

The Defense Health Agency (DHA) launched this donation drive on June 1 through its more than 20 Armed Services Blood Program (ASBP) centers across the continental United States and overseas to collect plasma to support the development of an effective treatment for those seriously ill with the virus.

As of Nov. 30, 204 patients within the MHS had been transfused 322 units of CCP, said ASBP Division Chief Army Col. Audra Taylor. Typically, one or two units are administered to each patient. At the outset of COVID, when CCP became available as an investigational product by the Food and Drug Administration, the treatment was for severely ill patients.

“Since those early days, the recommendations for treatment are earlier,” Taylor noted.

Almost all patients who require supplemental oxygen now also get CCP, noted Air Force Col. Stacy Shackelford, Joint Trauma System chief.

The immune system of a COVID-19-positive patient creates infection-fighting antibodies contained in their plasma. Plasma with these infection-fighting antibodies is called "convalescent plasma." By donating blood or plasma, a patient who has recovered fully provides CCP rich in antibodies to a sick patient who is still fighting the virus to boost their immune system and help them recover.

Female technician making sure bags of CCP are secure
Navy Hospital Corpsman 3rd Class Bailey Carter, assigned to U.S. Naval Hospital Guam, secures blood donations collected from sailors who recovered from COVID-19 this spring. The DOD surpassed its goal by collecting more than 10,000 CCP units. (Photo by Jaciyn Matanane, Naval Hospital Guam.)

Since the close of the initial CCP drive, the Armed Services Blood Program (ASBP) has transitioned to a plan to ensure adequate supplies of CCP for future DOD beneficiaries.

“The ASBP recruiters and blood donor centers continue to use the tools and processes developed for the recruitment of potential donors to support the sustainment of the Department of Defense CCP inventory,” Taylor said, adding that “the designated inventory levels sustain the Military Health System, including the combatant commands.”

Unfortunately, CCP has a one-year shelf life, so collected units will begin to expire in 2021.

Therefore, there is no end date for collection, Taylor noted. A new CCP collection challenge comes with the new COVID-19 vaccines, which, when approved by FDA and distributed for vaccination, will “have an impact on the availability of potential donors as the vaccines come with a deferral period,” she explained.

At a Nov. 16 ceremony honoring the success of the CCP drive, Army Lt. Gen. (Dr.) Ronald Place, director of the Defense Health Agency, said: “In my opinion, that’s the best kind of outcome for our health system.”

The reforms to military medicine remain inspired by the belief that a well-integrated organization across functions, across military departments, and unified in its strategic execution, both internally and with our partners in civilian medicine, strengthens the health and readiness of our force, he explained.

To donate convalescent plasma, donors must meet basic donation requirements. Donations can be done through whole blood or apheresis, a form of plasma collection.

To qualify for the program, participants must:

  • Have evidence of COVID-19 documented by two FDA-approved serological tests for SARS-CoV-2 antibodies after recovery, if prior diagnostic testing was not performed at the time COVID-19 was suspected.
  • Have a complete resolution of symptoms at least 14 days before donation.
  • Undergo potential additional testing if ever pregnant to determine if HLA antibodies have developed.

The DOD’s primary goals against the pandemic are to protect its people, maintain readiness and support the national COVID-19 response. In addition to aiding in the development of new therapeutic treatments for COVID-19-positive patients in DOD facilities, CCP contributes to the overall efforts to combat the disease, thus helping accomplish each of those goals.

You also may be interested in...

DHA leadership recognizes, advances 60th MDG mission

Article
5/14/2021
Army Lt. Gen. Ronald Place visits Travis Air Force Base

DHA leadership visit 60th Medical Group at Travis AFB.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit | MHS GENESIS

Teamwork, adaptability, service – MTFs shine during COVID-19 pandemic

Article
5/14/2021
People at screening area

MHS readiness was put to the test at the onset of the COVID-19 pandemic, in early 2020.

Recommended Content:

May Toolkit | May Military and Health Observances | COVID-19 Vaccine Toolkit | Coronavirus

Join Us!! Sixth Live COVID-19 Town Hall

Article
5/12/2021
Image describing today's Town Hall with Dr. Paul Scott and COL Clinton K. Murray, MD.  They are with the Walter Reed Army Institute of Research, and will discuss COVID-19 Vaccine Advancement and Trials.

Join us for today's Town Hall with Dr. Paul Scott and COL Clinton K. Murray, MD. They are with the Walter Reed Army Institute of Research, and will discuss COVID-19 Vaccine Advancement and Trials.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

MHS Town Hall, May 12, 2021

Video
5/12/2021
MHS and Military OneSource COVID-19 Townhall, Walter Reed Army Institute of Research, Wednesday 12 May

Tune in for another MHS and Military OneSource Town Hall with the Walter Reed Army Institute of Research

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Is It Allergies or COVID-19?

Infographic
5/11/2021
Infographic that describes the difference between symptoms of allergies and those related to COVID-19

This Infographic provides a chart that outlines how to tell the difference between COVID-19 and allergy symptoms

Recommended Content:

Symptoms of COVID-19 | Coronavirus | COVID-19 Vaccine Toolkit

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

Navy nurse steps into Jacksonville community for COVID-19 vaccinations

Article
5/7/2021
Military health personnel wearing face mask discussing the COVID-19 vaccine program

Navy Cmdr. Glenn “Pete” Bradford is aiding the underserved Jacksonville community in COVID-19 vaccination mission

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Line Leader Presentation (PDF)

Publication
5/7/2021

This document is identical to the PowerPoint presentation for line leader reference and use.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Reasons to Choose a COVID-19 Vaccine Fact Sheet

Publication
5/7/2021

Leaders and public affairs officers can share this information across channels to continue the vaccine confidence conversation.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Line Leader Presentation PPT

Publication
5/7/2021

Leaders across the Department can leverage this briefing deck to discuss COVID-19 vaccines with their troops. Don't forget to reference speaker notes and to personalize the title slide!

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Presentation Companion

Publication
5/7/2021

Leaders and public affairs officers may reference this document. It can be shared with commands to support briefings, or distributed independently to share facts about COVID-19 vaccines.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Nurse and Tech Week: Air Force airmen are battle-tested and ready

Article
5/6/2021
12 COVID-19 patients aboard a C-17 Globemaster III aircraft

For the past year, Air Force nurses and medical technicians have found themselves on the front lines in the battle against the COVID-19 disease.

Recommended Content:

COVID-19 Vaccine Toolkit | National Nurses Week | Technology | Nurses Week | May Toolkit | Coronavirus

EACH celebrates National Nurses Week with a reflection on the pandemic

Article
5/6/2021
Military health personnel inputting information into a computer

Evans Army Community Hospital celebrates National Nurses Week 2021.

Recommended Content:

National Nurses Week | Nurses Week | Coronavirus | COVID-19 Vaccine Toolkit

DHA, HA leaders discuss MHS Transformation at AHA panel

Article
5/6/2021
Military personnel talking at a podium

Army Lt. Gen. (Dr.) Ronald Place and Dr. Terry Adirim discussed MHS Transformation, MHS GENESIS, and highlighted the DHA’s response to COVID-19 in a virtual roundtable hosted April 12 by the American Hospital Association.

Recommended Content:

MHS GENESIS | MHS Transformation | Genesis of MHS GENESIS | Coronavirus

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 33

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.